Revista Española de Cardiología (English Edition) Revista Española de Cardiología (English Edition)
Rev Esp Cardiol. 2012;65:713-8 - Vol. 65 Num.08 DOI: 10.1016/j.rec.2012.02.019

Utilization of Evidence-based Cardiovascular Therapies and Achievement of Therapeutic Goals in Patients With Peripheral Artery Disease

José M. Mostaza a,, Enrique Puras b, Mariano Blasco c, Carlos Lahoz a, María L. Samaniego d

a Unidad de Arteriosclerosis y Riesgo Vascular, Hospital Carlos III, Madrid, Spain
b Servicio de Angiología y Cirugía Vascular, Hospital Universitario de Alcorcón, Alcorcón, Madrid, Spain
c Centro de Salud Delicias Sur, Zaragoza, Spain
d Departamento de Estadística, Pfizer, Madrid, Spain

Keywords

Peripheral arterial disease. Risk factors. Angiotensin converting enzyme inhibitors. Atherosclerosis. Smoking.

Abstract

Introduction and objectives

Patients with peripheral artery disease have a high risk of cardiovascular events and death. The rate of prescription of evidence-based cardiovascular therapies and the attainment of therapeutic goals in this population is suboptimal. There are no previous studies evaluating the rate of prescription of these therapies in our country.

Methods

PERIFERICA is a cross-sectional study conducted from May to December 2009 in 440 outpatient clinics of general practitioners, internal medicine, cardiology, vascular surgery, endocrinology, and nephrology specialists throughout Spain. Subjects were included if they were aged ≥45 years and had peripheral artery disease and a blood sample obtained during the previous 6 months. Patients were excluded if they had coronary or cerebrovascular diseases. Clinical and anthropometric variables and blood analysis were obtained in all participants.

Results

In total, 4087 patients were included in the study (mean age, 68 years; 74% men). There was a high prevalence of diabetes (50%) and hypertension (90%); 79% of participants received lipid-lowering drugs (76% statins), 85.5% antihypertensive drugs (66% renin-angiotensin blockers) and 83% antithrombotics (75% antiplatelet drugs and 11% anticoagulants). In addition, 30% of subjects had a low-density lipoprotein cholesterol concentration n<100mg/dL, 29.5% had optimal control of blood pressure, and 74.5% did not smoke. Only 8% had a good control of all of their cardiovascular risk factors.

Conclusions

Although a high percentage of subjects with peripheral artery disease receives adequate treatment with evidence-based preventive therapies, the percentage of subjects with good control of all their risk factors is low.

1885-5857/© 2012 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved

Cookies
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.
Cookies policy
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.